Centro de Investigación de Medicina Aplicada (CIMA)
Centro / Instituto vinculado a la Universidad de Navarra
Maastricht University
Maastricht, HolandaPublicaciones en colaboración con investigadores/as de Maastricht University (11)
2021
-
Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity
Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 9
2018
-
MicroRNA-221/222 family counteracts myocardial fibrosis in pressure overload-induced heart failure
Hypertension, Vol. 71, Núm. 2, pp. 280-288
2017
-
A Urinary Fragment of Mucin-1 Subunit α Is a Novel Biomarker Associated With Renal Dysfunction in the General Population
Kidney International Reports, Vol. 2, Núm. 5, pp. 811-820
-
Novel urinary peptidomic classifier predicts incident heart failure
Journal of the American Heart Association, Vol. 6, Núm. 8
2016
2015
-
Biomarkers of cardiomyocyte injury and stress identify left atrial and left ventricular remodelling and dysfunction: A population-based study
International Journal of Cardiology, Vol. 185, pp. 177-185
-
Coronary risk in relation to genetic variation in MEOX2 and TCF15 in a Flemish population
BMC Genetics, Vol. 16, Núm. 1
2012
-
Prevalence of left ventricular diastolic dysfunction in European populations based on cross-validated diagnostic thresholds
Cardiovascular Ultrasound, Vol. 10, Núm. 1
2009
-
Identification and characterization of HMBS gene mutations in Spanish patients with acute intermittent porphyria
Cellular and Molecular Biology, Vol. 55, Núm. 2, pp. 55-63
-
Prevalence of left ventricular diastolic dysfunction in a general population
Circulation: Heart Failure, Vol. 2, Núm. 2, pp. 105-112
2005
-
Annexin A5 down-regulates surface expression of tissue factor: A novel mechanism of regulating the membrane receptor repertoir
Journal of Biological Chemistry, Vol. 280, Núm. 7, pp. 6028-6035